Business Description
Avricore Health Inc
NAICS : 621512
SIC : 8689
ISIN : CA92143R2046
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 19.78 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.07 | |||||
Interest Coverage | 11.7 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | -5.83 | |||||
Beneish M-Score | -3.22 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 227.1 | |||||
3-Year EBITDA Growth Rate | 43.9 | |||||
3-Year EPS without NRI Growth Rate | 16.2 | |||||
3-Year FCF Growth Rate | 41.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 9.73 | |||||
9-Day RSI | 23.32 | |||||
14-Day RSI | 27.88 | |||||
6-1 Month Momentum % | -66.67 | |||||
12-1 Month Momentum % | -67.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.62 | |||||
Quick Ratio | 2.62 | |||||
Cash Ratio | 1.48 | |||||
Days Inventory | 1.62 | |||||
Days Sales Outstanding | 33.17 | |||||
Days Payable | 56.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 37.98 | |||||
Operating Margin % | 2.48 | |||||
Net Margin % | 2.2 | |||||
FCF Margin % | 7.48 | |||||
ROE % | 4.81 | |||||
ROA % | 3.87 | |||||
ROIC % | 6.86 | |||||
ROC (Joel Greenblatt) % | 6.29 | |||||
ROCE % | 4.77 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.33 | |||||
PE Ratio without NRI | 18.33 | |||||
PEG Ratio | 0.39 | |||||
PS Ratio | 1.17 | |||||
PB Ratio | 2.2 | |||||
Price-to-Tangible-Book | 2.75 | |||||
Price-to-Free-Cash-Flow | 13.75 | |||||
Price-to-Operating-Cash-Flow | 6.88 | |||||
EV-to-EBIT | 51.69 | |||||
EV-to-EBITDA | 9.32 | |||||
EV-to-Revenue | 1.13 | |||||
EV-to-FCF | 16.52 | |||||
Price-to-Graham-Number | 1.38 | |||||
Price-to-Net-Current-Asset-Value | 5.5 | |||||
Earnings Yield (Greenblatt) % | 1.94 | |||||
FCF Yield % | 6.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Avricore Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 4.718 | ||
EPS (TTM) (C$) | 0.003 | ||
Beta | 0.3 | ||
Volatility % | 106.88 | ||
14-Day RSI | 27.88 | ||
14-Day ATR (C$) | 0.006308 | ||
20-Day SMA (C$) | 0.0685 | ||
12-1 Month Momentum % | -67.65 | ||
52-Week Range (C$) | 0.05 - 0.335 | ||
Shares Outstanding (Mil) | 101.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Avricore Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Avricore Health Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Avricore Health Inc Frequently Asked Questions
What is Avricore Health Inc(TSXV:AVCR)'s stock price today?
When is next earnings date of Avricore Health Inc(TSXV:AVCR)?
Does Avricore Health Inc(TSXV:AVCR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |